Marex Group »

Lakewood-amedex Biotherapeut shares owned by Marex Group

Quarter-by-quarter ownership of Lakewood-amedex Biotherapeut shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Lakewood-amedex Biotherapeut

Tip: Access up to 7 years of quarterly data

All positions including Lakewood-amedex Biotherapeut held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lakewood-amedex Biotherapeut by Marex Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $151k 48k 3.14

More positions owned by Marex Group

Sandisk Corp Call Option (SNDK)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Broadcom Put Option (AVGO)
Microsoft Corporation Put Option (MSFT)
Applied Optoelectronics Put Option (AAOI)
Ast Spacemobile Com Cl A Call Option (ASTS)
Marvell Technology (MRVL)
Lumentum Hldgs Put Option (LITE)
Eli Lilly & Co. Put Option (LLY)
NVIDIA Corporation Put Option (NVDA)
UnitedHealth Put Option (UNH)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors Call Option (TSLA)
Axt (AXTI)
Space Exploration Techn Corp Class A Com Stk (SPCX)

View all positions for Marex Group

Top funds holding Lakewood-amedex Biotherapeut

Marex Group
Hrt Financial
UBS Group
Tower Research Capital
Advisor Group Holdings
Ronald Blue Trust

View all funds holding Lakewood-amedex Biotherapeut